Company / Operating Income
BeOne Medicines Ltd. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$447.1M
FY2025
5-year range
-$1.8B / $447.1M
FY2021-FY2025
Trend
+178.7%
vs FY2024
Sector context
#18 of 204
Health Care
What the data says
Among 204 Health Care companies, BeOne Medicines Ltd. is in the top 9% for operating income. Operating Income has increased for 3 consecutive years, from -$1.8B in FY2022 to $447M in FY2025.
Based on SEC 10-K filings.
$447M in FY2025. Top quartile in the Health Care sector.
Improved from -$1.2B to $447M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 204This company $447.1M Sector average $107.8M
▼
+315.0% above sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s operating income has grown for 3 consecutive years.
- In FY2025, operating income increased 178.7% year-over-year.
- Ranks #18 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $447.1M | +178.7% |
| FY2024 | -$568.2M | +53.0% |
| FY2023 | -$1.2B | +32.5% |
| FY2022 | -$1.8B | -24.4% |
| FY2021 | -$1.4B | +13.2% |
| FY2020 | -$1.7B | -72.7% |
| FY2019 | -$959.9M | -36.0% |
| FY2018 | -$705.8M | -616.8% |
| FY2017 | -$98.5M | +15.9% |
| FY2016 | -$117.1M | -106.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026